JPH0368503A - Liquid medicine for contact lens - Google Patents

Liquid medicine for contact lens

Info

Publication number
JPH0368503A
JPH0368503A JP1205372A JP20537289A JPH0368503A JP H0368503 A JPH0368503 A JP H0368503A JP 1205372 A JP1205372 A JP 1205372A JP 20537289 A JP20537289 A JP 20537289A JP H0368503 A JPH0368503 A JP H0368503A
Authority
JP
Japan
Prior art keywords
contact lens
lens
preservative
liquid medicine
adsorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1205372A
Other languages
Japanese (ja)
Other versions
JPH0816042B2 (en
Inventor
Hiroaki Miichi
見市 博明
Takeshi Masumoto
桝本 健
Hiroo Nitta
博夫 新田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rohto Pharmaceutical Co Ltd
Original Assignee
Rohto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rohto Pharmaceutical Co Ltd filed Critical Rohto Pharmaceutical Co Ltd
Priority to JP1205372A priority Critical patent/JPH0816042B2/en
Publication of JPH0368503A publication Critical patent/JPH0368503A/en
Publication of JPH0816042B2 publication Critical patent/JPH0816042B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Eyeglasses (AREA)

Abstract

PURPOSE:To obtain the subject liquid medicine almost free from affinity to hard and soft contact lens having a high oxygen permeability, free from adsorption on the lens and deposition on the lens and having a sufficient rotproof effect by admixing a glycine type ampholytic surfactant with a nonionic surfactant. CONSTITUTION:With a glycine type ampholytic surfactant having a high germicidal action against Pseudomonas aeruginosa, fungi and general bacteria, a suitable amount of a nonionic surfactant is admixed to obtain the objective liquid medicine for contact lens capable of preventing generation of slight turbidity due to the glycine type ampholytic surfactant, capable of preventing adsorption thereof on the contact lens, free from stimulation to the eyes, having a high stability and excellent in rotproof effect. The obtained liquid medicine can be used as an eye drop for both of oxygen-permeable hard and soft contact lens and also can be used as a germicidal preservative and a wash preservative.

Description

【発明の詳細な説明】 (発明の背景) 視力補正用のコンタクトレンズは、元来ポリメチルメタ
クリレート(以下PMMA)を素材としたいわゆるハー
ドコンタクトレンズ(以下HCL)として実用化され、
その後ポリハイドロキシエチルメタクリレート(以下P
HEMA)を素材とした含水性のソフトコンタクトレン
ズ(以下5CL)か登場し、コンタクトレンズは大きく
ハードとソフトに区分されてきた。
[Detailed Description of the Invention] (Background of the Invention) Contact lenses for vision correction were originally put into practical use as so-called hard contact lenses (hereinafter referred to as HCL) made of polymethyl methacrylate (hereinafter referred to as PMMA).
After that, polyhydroxyethyl methacrylate (hereinafter P
With the advent of water-containing soft contact lenses (hereinafter referred to as 5CL) made from HEMA, contact lenses have been broadly divided into hard and soft.

しかしながら、従来のPMMAでつくられたトICLは
酸素透過性かほとんどなく、そのため、装用感が悪く、
またオーバーウェアーによる眼障害を起こしたり、最近
では長期間の使用による角膜内皮への影響も懸念されて
いる。そこで酸素透過性に優れたプラスチック素材が次
々とコンタクトレンズに応用され、従来のレンズに比べ
酸素透過性が飛躍的に向上したハードコンタクトレンズ
が市場に登場してきた。
However, conventional ICLs made of PMMA have very little oxygen permeability, and therefore are uncomfortable to wear.
There are also concerns that overwear may cause eye damage, and that long-term use may have an effect on the corneal endothelium. Therefore, plastic materials with excellent oxygen permeability have been applied to contact lenses one after another, and hard contact lenses, which have dramatically improved oxygen permeability compared to conventional lenses, have appeared on the market.

これらのハードコンタクトレンズは、酸素透過性ハード
コンタクトレンズ(以下GPHCL)と呼ばれ、主に、
セルロース アセテート ブチレート(CAB)やシロ
キサニールアルキルメタクリレートにPMMA、グリコ
ールジメチルメタクリレート、ジメチルイタコネート及
びPHEMA等を適切な量比で共重合させたシリコーン
アクリレート系ポリマーや、フロロメタクリレートと主
にPMMAやシロキサニールアルキルメタクリレートを
共重合させたフロロシリコンアクリレート系からなる。
These hard contact lenses are called oxygen-permeable hard contact lenses (GPHCL), and are mainly made of
Silicone acrylate polymers are made by copolymerizing cellulose acetate butyrate (CAB) or siloxaneyl alkyl methacrylate with PMMA, glycol dimethyl methacrylate, dimethyl itaconate, PHEMA, etc. in appropriate ratios, and fluoromethacrylate and mainly PMMA or siloxane. It is made of fluorosilicone acrylate copolymerized with rualkyl methacrylate.

これらのGPHCLは、PMMAからなる従来のHCL
に比べると、酸素透過性は格段に向上し当初の目的を果
たしたが、欠点として一般にレンズ素材が脆弱で物理的
な外力により傷がつきやすく、また生体の成分や化学物
質との親和性が高い。したがって、汚れやすく、薬物の
影響を受けやすい性質を有している。
These GPHCLs are different from conventional HCLs made of PMMA.
The oxygen permeability was significantly improved and the original objective was achieved, but the drawbacks are that the lens material is generally fragile and easily scratched by external physical forces, and that it has poor affinity with biological components and chemicals. expensive. Therefore, it is easily soiled and easily affected by drugs.

一方、PHEMAのみからなるSCLではHCL同様、
酸素透過性が小さく、オーバーウェアーの問題があり、
また最近では、連続装用も可能となる’<< PHEM
Aに主としてN−ビニルピロリドンを加えたものや、P
MMAにN−ビニルピロリドンやグリセリルメタクリレ
ートを加えたもの、さらには、ブチルアクリレートとブ
チルメタクリレートとを主成分にした非含水性のSCL
のように素材開発が進む一方、レンズの厚みや含水率に
も改良が加えられ、酸素透過性か高められたSCLが実
際に商品化され市場に出てきた。しかし、これらのSC
LもGPHCL同様、素材的には脆弱になり、PHEM
AのみからなるSCLに比べより薬液等の化学物質の影
響を受けやすくなっている。
On the other hand, in SCL consisting only of PHEMA, like HCL,
Oxygen permeability is low and there is an overwear problem.
Recently, it has also become possible to wear it continuously'<< PHEM
A with mainly N-vinylpyrrolidone added, or P
MMA with N-vinylpyrrolidone and glyceryl methacrylate added, as well as non-hydrous SCL whose main components are butyl acrylate and butyl methacrylate.
While material development progressed, improvements were made to the thickness and water content of lenses, and SCL with increased oxygen permeability was actually commercialized and released on the market. However, these SC
Like GPHCL, L is also fragile in terms of material, and PHEM
Compared to SCL consisting only of A, it is more susceptible to the effects of chemical substances such as chemical solutions.

(解決しようとする問題点) HCL、、SCLを問わず、コンタクトレンズ装着中の
眼の乾燥感、くもり、異物感といった眼の障害は極めて
よく発生し、コンタクトレンズ装着中に点眼薬で涙液の
補給をしたり、装用前に装用をスムーズにするために、
ウエソティングソルーションが強く求められている。一
方、GPHCLでは新しく素材開発されたことによって
、先にも述べたごとく、取扱いの問題としてレンズが汚
れやすくなってきたことがあげられる。従って、GPH
CLを長期に渡って安全に取り扱ってゆくには、従来の
HCLにも増して装着後の取扱いに細心の注意が払われ
なければならない。特にGPHCLでは、装用後の洗浄
並びに−夜浸漬保存が装用中の汚れを除去する上で効果
的であり、GPHCL専用の洗浄液や保存液といったコ
ンタクトレンズ用液剤が必要となる。
(Problem to be solved) Regardless of whether it is HCL or SCL, eye disorders such as dryness, cloudiness, and foreign body sensation occur very often while wearing contact lenses. In order to replenish the amount of water and make the wearing process smooth before wearing,
There is a strong need for a usoting solution. On the other hand, with the development of new materials for GPHCL, as mentioned earlier, the lens has become easier to get dirty as a handling problem. Therefore, GPH
In order to safely handle CL over a long period of time, even more care must be taken in handling it after installation than with conventional HCL. In particular, for GPHCL, cleaning after wearing and overnight soaking are effective in removing stains during wearing, and a contact lens solution such as a cleaning solution or a storage solution specifically for GPHCL is required.

更に、上記の点眼薬やウェッティングソルーションは、
開封前はもとより、開封後も長期に渡り無菌性を維持す
る必要がある。しかしながら、これらの液剤は、その使
用目的から、手指や眼粘膜からの細菌汚染の確率が高く
、従って細菌の繁殖を抑え死滅させる防腐剤の添加が必
要となる。更に、保存液にあっては、汚れたレンズを長
時間溶液中に浸漬保存しておく為、当然防腐剤の添加が
必須となる。
Furthermore, the eye drops and wetting solutions mentioned above
It is necessary to maintain sterility not only before opening, but also for a long period of time after opening. However, due to the intended use of these liquid preparations, there is a high probability of bacterial contamination from fingers and eye mucous membranes, and therefore it is necessary to add a preservative to suppress and kill bacterial proliferation. Furthermore, since dirty lenses are immersed in the solution for a long period of time, it is necessary to add a preservative to the storage solution.

従来、これらのコンタクトレンズ用液剤には防腐剤とし
て、塩化ベンザルコニウム(以下BAK)や塩化ベンゼ
トニウム等のカチオン界面活性剤、グルコン酸クロルヘ
キシジン(以下GCH)、クロロブタノール、パラアミ
ノ安息香酸エステル、ソルビン酸及びチメロサールなど
が単独で、あるいは適当に組合わせて用いられてきた。
Conventionally, these contact lens solutions contain preservatives such as cationic surfactants such as benzalkonium chloride (BAK) and benzethonium chloride, chlorhexidine gluconate (GCH), chlorobutanol, para-aminobenzoic acid ester, and sorbic acid. and thimerosal have been used alone or in appropriate combinations.

しかしながう、カチオン界面活性剤やGCH,パラアミ
7安息香酸エステルは、GPHCLやSCLと非常に親
和性が高く、これらが配合された点眼薬、コンタクトレ
ンズ洗浄剤、或は保存液を用いると、これらの防腐剤が
レンズに吸着、蓄積されてゆく。
However, cationic surfactants, GCH, and para-amino-7 benzoate have a very high affinity with GPHCL and SCL, and if eye drops, contact lens cleaning agents, or storage solutions containing these are used, , these preservatives are adsorbed and accumulated on the lens.

さらに、これらの防腐剤が蓄積されたコンタクトレンズ
を装用すると、眼障害を起こす可能性が非常に高くなる
。また、GPHCLにおいては、防腐剤の吸着、蓄積に
由来する、レンズ表面のクラックでレンズの白濁が生じ
たり、またレンズの膨潤により、コンタクトレンズのサ
イズ、ベースカーブ、パワー及び中心厚の大幅な規格変
化が生じることがあり、それに由来する物理的な眼障害
をまねく恐れもある。さらに、SCLにおいては、国内
では煮沸滅菌が義務づけられているが、−旦、SCLに
吸着された防腐剤が除去されないまま煮沸滅菌処理され
ると、SCLの表面、内部で防腐剤が変性、固着し、容
易にレンズから溶出し得ない状況に陥り、かかる有害成
分が除々に蓄積されることになる。
Furthermore, wearing contact lenses with a build-up of these preservatives greatly increases the possibility of eye damage. In addition, in GPHCL, lens cloudiness occurs due to cracks on the lens surface due to adsorption and accumulation of preservatives, and swelling of the lens causes drastic changes in the size, base curve, power, and center thickness of contact lenses. Changes may occur, which may lead to physical eye damage. Furthermore, boiling sterilization is mandatory for SCL in Japan, but if the preservative adsorbed on SCL is boiled and sterilized without being removed, the preservative will denature and stick on the surface and inside of SCL. However, such harmful components gradually accumulate in a situation where they cannot be easily eluted from the lens.

米国のSCL用剤をみると(Nonprescript
ionDrugs 8th edition)、煮沸滅
菌時に用いるコンタクトレンズ用液剤には防腐剤として
カチオン界面活性剤やG Cf(の配合はみられず、グ
ルコン酸クロルヘキシジンはもっばらコールド滅菌に用
いられているのも上記の理由からである。なお、米国で
の煮沸滅菌時の重刑にはチメロサールとソルビン酸が用
いられている。しかしチメロサールは人体内への蓄積と
環境汚染の問題から、国内での使用は難しく、後者は、
本来防腐力が弱く、コンタクトレンズ用液剤として具備
すべき十分な防腐効果を保証し得ない。
Looking at SCL drugs in the US (Nonprescript
ionDrugs 8th edition), contact lens solutions used during boiling sterilization do not contain cationic surfactants or G Cf as preservatives, and chlorhexidine gluconate is mostly used for cold sterilization. This is because of the following reasons.In addition, thimerosal and sorbic acid are used for severe punishment during boiling sterilization in the United States.However, thimerosal is difficult to use in Japan due to problems of accumulation in the human body and environmental pollution. The latter is
It inherently has weak preservative power and cannot guarantee the sufficient preservative effect that a contact lens solution should have.

以上述べたとおり、従来からコンタクトレンズ用液剤に
用いられてきた防腐剤には、最近開発されてきた酸素透
過性の高いハード及びソフトコンタクトレンズに対し用
いることができるものは全く存在しなかった。
As described above, among the preservatives conventionally used in contact lens solutions, there was no preservative that could be used in the recently developed hard and soft contact lenses with high oxygen permeability.

(問題を解決するための手段) 本発明者らは、コンタクトレンズ用液剤に使用可能な防
腐剤について検討を重ねた結果、従来の防腐剤に比べる
と、酸素透過性の高いハード及びソフトコンタクトレン
ズに対してほとんど親和性がなく、従ってレンズに吸着
、蓄積せず、しかも十分な防腐力をもたらすことができ
るものとして、グリシン型両性界面活性剤が極めて優れ
ていることを見い出した。グリシン型両性界面活性剤は
、通常塩酸塩として用いられ、以下の一般式で表される
: [R’ −(NHCII2CHf)t −N11C11
,C00I+]・llCl  ・・・・・・・■[(R
’NHCl1.CI+、) 、NCH,C0OH]・l
lCl     ・・・・・・■[式中、R1はC8〜
CI8アルキル基、R1はC8アルキル基を示す]。
(Means for Solving the Problem) As a result of repeated studies on preservatives that can be used in contact lens solutions, the present inventors found that hard and soft contact lenses with high oxygen permeability compared to conventional preservatives. We have discovered that glycine-type amphoteric surfactants are extremely excellent as they have almost no affinity for lenses, therefore do not adsorb or accumulate on lenses, and can provide sufficient preservative power. Glycine type amphoteric surfactants are usually used as hydrochloride salts and are represented by the following general formula: [R'-(NHCII2CHf)t-N11C11
,C00I+]・llCl ・・・・・・・■[(R
'NHCl1. CI+, ), NCH, C0OH]・l
lCl ・・・・・・■ [In the formula, R1 is C8~
CI8 alkyl group, R1 represents a C8 alkyl group].

グリシン型両性界面活性剤の1つはTEGO[F]とい
う商品名で市販されており、TEGO−51゜は上記■
式の構造をもち、R1はC,H,、〜C1,H3゜のア
ルキル基である。また、TEGO−103゜とよばれる
市販品は上記■式の構造をもつ。
One of the glycine-type amphoteric surfactants is commercially available under the trade name TEGO [F], and TEGO-51° is the product listed above.
It has the structure of the formula, and R1 is an alkyl group of C, H, .about.C1,H3°. Furthermore, a commercially available product called TEGO-103° has the structure of the above formula (2).

これらグリシン型両性界面活性剤は緑膿菌や真菌および
一般細菌に対し強力な殺菌作用を有しており、医療2g
具や手術室の殺菌消毒、浴用剤、水虫治療剤さらに手術
野の消毒など医療方面にも広く使用されている。
These glycine-type amphoteric surfactants have a strong bactericidal effect against Pseudomonas aeruginosa, fungi, and general bacteria, and
It is also widely used in the medical field, including sterilizing instruments and operating rooms, bath preparations, athlete's foot treatments, and disinfecting surgical fields.

グリシン型両性界面活性剤は、0.001−01%(w
/v%;以下に示す%は全でw/v%である)の濃度で
良好な防腐効果が得られるが、種々濃度の水溶液を緩衝
剤や等張化剤を加えずに調製すると、一定の濃度域の消
波について外観上かすかな濁りが観察される。TEGO
−51oを用いて観察した結果を以下の表1に示す。
Glycine type amphoteric surfactants are 0.001-01% (w
/v%; all percentages shown below are w/v%). However, when aqueous solutions of various concentrations are prepared without adding a buffer or isotonic agent, the concentration is constant. A slight turbidity is observed in the appearance regarding the wave dissipation in the concentration range of . TEGO
The results observed using -51o are shown in Table 1 below.

表1. T EGO−51”水溶i&l:+性状コンタ
クトレンズ用肢剤にあっては、澄明であることは必須条
件であり、上記のような現象は許容できない。このかす
かな濁りの本体は明らかではないが、本発明者らは、一
定の4W領域で発生するかすかな濁りを防止するべく、
種々の添加剤を検討した結果、非イオン界面活性剤を適
切な量で加えることにより、このかすかな濁りの発生を
防止し、さらに後述のとおり、グリシン型両性界面活性
剤のコンタクトレンズへの吸着を抑制することを見いだ
した。非イオン界面活性剤としては、たとえば ポリオキシエチレンソルビタン脂肪酸エステル(TO−
100) ポリオキシエチレンアルキルフェニルエーテル(例:0
P−10o)、 ポリオキシエチレンアルキルエステル(例:MYS−4
0■)、 ポリオキシエチレンアルキルエーテル(例:BL−9E
X■)、 ポリオキシエチレン硬化ヒマシ油(HCO−60”)等
が挙げられる。これらの非イオン界面活性剤は、日本薬
局方や化粧品原料基準等の公定書に収載されており、注
射剤や薬用化粧品の添加剤として広く用いられている。
Table 1. TEGO-51" water-soluble i&l:+ propertiesFor contact lens additives, clarity is an essential condition, and the above phenomenon cannot be tolerated.The actual cause of this slight turbidity is not clear, but In order to prevent the slight turbidity that occurs in a certain 4W area, the present inventors
As a result of examining various additives, we found that by adding an appropriate amount of nonionic surfactant, we were able to prevent this slight clouding and, as will be explained later, to improve the adsorption of glycine-type amphoteric surfactant onto contact lenses. was found to suppress Examples of nonionic surfactants include polyoxyethylene sorbitan fatty acid ester (TO-
100) Polyoxyethylene alkyl phenyl ether (e.g. 0
P-10o), polyoxyethylene alkyl ester (e.g. MYS-4
0 ■), polyoxyethylene alkyl ether (e.g. BL-9E
X■), polyoxyethylene hydrogenated castor oil (HCO-60”), etc.These nonionic surfactants are listed in the Japanese Pharmacopoeia, the official standards for cosmetic raw materials, etc., and are available as injections and It is widely used as an additive in medicinal cosmetics.

TEGO−51oの濁りを生ずる濃度領域で、上記非イ
オン界面活性剤を加え、外観を観察した結果を表2に示
す。
Table 2 shows the results of adding the above-mentioned nonionic surfactant at a concentration range that causes turbidity in TEGO-51o and observing the appearance.

0P−1ρ:ポリオキシエチレン(10)オクチルフェ
ニルエーテルMYS−40@):ポリオキシエチレン(
40)モノステアレートBL−9Ex@:ポリオキシエ
チレン(9〉ラウリルエーテルHCO−6ρ:ポリオキ
シエチレン(60)硬化ヒマシ油以上、いずれの非イオ
ン界面活性剤でも0.001%以上配合すれば、濁りを
防止できる。
0P-1ρ: Polyoxyethylene (10) octylphenyl ether MYS-40@): Polyoxyethylene (
40) Monostearate BL-9Ex@: polyoxyethylene (9> lauryl ether HCO-6ρ: polyoxyethylene (60) hydrogenated castor oil or more, if any nonionic surfactant is blended at 0.001% or more, Can prevent turbidity.

また、非イオン界面活性剤の配合濃度は、0゜001%
でも澄明な水溶液が得られるが、コンタクトレンズ用液
剤を長期間に渡り澄明に保ち、しかもコンタクトレンズ
へのグリシン型両性界面活性剤の吸着を抑制するために
は、点眼薬にあっては0.01〜0.5%の範囲で、ま
たその他のコンタクトレンズ用液剤にあっては0.01
〜2.5%の範囲が望ましい。
In addition, the blending concentration of nonionic surfactant is 0°001%.
However, in order to keep the contact lens solution clear for a long period of time and to suppress the adsorption of the glycine-type amphoteric surfactant to the contact lens, eye drops must have a 0. 0.01% to 0.5%, and 0.01% for other contact lens solutions.
A range of 2.5% is desirable.

本発明のコンタクトレンズ用液剤には、塩化ナトリウム
、塩化カリウム、リン酸水素ナトリウム、ホウ酸、ホウ
砂、クエン酸といった無機塩類をpH調整剤、等張化剤
、緩衝剤として用いることができ、また、安定化剤とし
てエチレンジアミン四酢酸塩(例:ナトリウム塩)さら
にはポリビニルアルコールやポリビニルピロリドン、ヒ
ドロキシエチルセルロースといった増結剤も加えること
ができる。
In the contact lens solution of the present invention, inorganic salts such as sodium chloride, potassium chloride, sodium hydrogen phosphate, boric acid, borax, and citric acid can be used as pH adjusters, tonicity agents, and buffering agents. Further, as a stabilizer, ethylenediaminetetraacetate (eg, sodium salt) and a binder such as polyvinyl alcohol, polyvinylpyrrolidone, or hydroxyethylcellulose can be added.

本発明の液剤の製造に当たっては、特殊な手法を特に必
要とせず、通常の水溶液剤を作る場合と同じく、所定量
の滅菌精製水を用いて各成分を溶解させ、澄明な水溶液
かえられた後、無菌ろ過、無菌充填を行えばよい。
In manufacturing the liquid preparation of the present invention, no special method is required, and in the same way as when making a normal aqueous solution, each component is dissolved using a predetermined amount of sterile purified water, and a clear aqueous solution is obtained. , sterile filtration, and sterile filling.

つぎに、本発明の具体的な調製例と各種コンタクトレン
ズに対する効果を他の防腐剤と比較検討した実施例を示
す。なお、以下の検討においては、グリシン型両性界面
活性剤としてすべてTEGO51oを使用したが、他の
グリシン型両性界面活性剤を使用しても同様の効果が得
られることは言うまでもない。コンタクトレンズは、以
下に列挙する市販の、未使用のものを用いた・。
Next, specific preparation examples of the present invention and examples in which the effects on various contact lenses were compared with other preservatives will be shown. In the following studies, TEGO51o was used as the glycine type amphoteric surfactant, but it goes without saying that similar effects can be obtained by using other glycine type amphoteric surfactants. The contact lenses listed below were commercially available and unused.

G P HCL   A (10種) B PMMA    K (1種) 非含水性5CLL (1種) 低含水性SCL  M (8種)  N 高含水性5CLU (2種)  ■ 実施例I TEGO−51o及び非イオン界面活性剤の所用量を無
機塩類とともに滅菌精製水で溶かした後、無菌的にろ過
し試料溶液を得る。試料溶液に用いた無機塩類は塩化ナ
トリウム、塩化カリウム、リン酸二水素ナトリウム、ホ
ウ酸及びホウ砂を含み、調製後のpHが7.2、浸透圧
か290 mo sm/ kgになるようにしたく以下
BUFFERと略称する)。
G P HCL A (10 types) B PMMA K (1 type) Low water content 5CLL (1 type) Low water content SCL M (8 types) N High water content 5CLU (2 types) ■ Example I TEGO-51o and non-water content After dissolving the required amount of ionic surfactant together with inorganic salts in sterile purified water, it is aseptically filtered to obtain a sample solution. The inorganic salts used in the sample solution include sodium chloride, potassium chloride, sodium dihydrogen phosphate, boric acid, and borax, and the pH after preparation should be 7.2 and the osmotic pressure should be 290 mo sm/kg. (hereinafter abbreviated as BUFFER).

GPHCL(8種)を以下の表3に示す各試料溶液およ
び比較溶液2+nlに浸漬し、34°Cで2時間インキ
ュベートした。防腐剤の吸着量は、液中の防腐剤濃度を
定量し、同様に操作したレンズなしの溶液との比較から
、インキュベート中に減少した防腐剤含量を算出し、レ
ンズへの吸着量とした。
GPHCL (8 types) was immersed in each sample solution and comparative solution 2+nl shown in Table 3 below, and incubated at 34°C for 2 hours. The amount of preservative adsorption was determined by quantifying the preservative concentration in the solution, and comparing it with a similarly operated solution without lenses to calculate the preservative content that decreased during incubation, which was taken as the amount of adsorption onto the lens.

以下の表3に、その結果を示す。Table 3 below shows the results.

従来のPMMAレンズでは、何れの防腐剤もほとんど吸
着は認められないが、G P I(CLの中には防腐剤
に対し非常に親和性のある素材のものが存在する。TE
GO−51■はBUFFER中のみでも、他の防腐剤(
BAK)と比べ比較的G P HCLに対する吸着は少
なく、また非イオン界面活性剤の配合によりほとんど吸
着はみられなかった。
In conventional PMMA lenses, almost no preservatives are adsorbed, but some GPI (CL) materials have a very high affinity for preservatives.TE
GO-51■ can be used only in BUFFER or without other preservatives (
Compared to BAK), adsorption to G P HCL was relatively small, and almost no adsorption was observed due to the inclusion of a nonionic surfactant.

実施例2 GPHCL(l 1種)を以下の試料溶液および比較溶
iff12mlに浸漬し、34°Cで1力月間保存した
のち、レンズのベースカーブ、パワー、サイズ及び中心
厚を測定すると共に外観を観察した。試料溶液の調製法
は実施例1と同様である。以下の表4にその結果を示す
Example 2 GPHCL (1 type) was immersed in 12 ml of the following sample solution and comparative solution iff, stored at 34°C for one month, and then the base curve, power, size, and center thickness of the lens were measured, and the appearance was examined. Observed. The method for preparing the sample solution is the same as in Example 1. The results are shown in Table 4 below.

た、クロロブタノールの配合された比較液は検討した全
てのGPHCLで規格の変動を起こした。
In addition, the comparative solution containing chlorobutanol caused variations in the specifications in all GPHCLs examined.

TEGO−51o配合の試料溶液では、レンズへの影響
は全く観察されなかった。
In the sample solution containing TEGO-51o, no effect on the lens was observed at all.

実施例3 非含水性ソフトコンタクトレンズ(1種)を、試料溶液
および比較溶液2川1に浸漬し、34°Cで2時間イン
キュベートしたのち、液中の防腐剤/RUを定量し、実
施例1と同様に吸着量を算出した。
Example 3 A non-water-containing soft contact lens (1 type) was immersed in a sample solution and a comparative solution 1, and incubated at 34°C for 2 hours, and then the preservative/RU in the solution was quantified. The adsorption amount was calculated in the same manner as in 1.

調製広は実施例1と同様におこなった。結果を以下の表
5に示す。
Preparation was carried out in the same manner as in Example 1. The results are shown in Table 5 below.

PMMAレンズでは、各種防腐剤によって、規格に影響
を受けることはなかったが、GPHCLでは、その配合
種により大きく影響をうけた。特に実施例1で防腐剤と
の親和性が比較的高かったレンズCは表面に微細なきす
が生じ白濁した。ま実施例1と同様TEGO−51■配
合の試料溶液は他の防腐剤を用いた比較溶液に比べ吸着
抑制が認められた。
For PMMA lenses, the specifications were not affected by various preservatives, but for GPHCL, the specifications were greatly affected by the type of formulation. In particular, Lens C in Example 1, which had a relatively high affinity with preservatives, had fine scratches on its surface and became cloudy. As in Example 1, the sample solution containing TEGO-51■ was found to be less adsorbed than the comparative solution containing other preservatives.

実施VA+4 低含水性5CL(1種)を下記の試料溶l夜および比較
溶液5IIllに浸漬し、25°Cで24時間インキュ
ベートしたのち、液中の防腐剤濃度を定量し、実施例1
と同様に吸着量を算出した。試料溶液の調製法は実施例
1と同様におこなった。結果を以下の表6に示す。
Implementation VA+4 Low water content 5CL (1 type) was immersed in the following sample solution and comparative solution 5IIll, and after incubating at 25°C for 24 hours, the preservative concentration in the solution was determined.
The adsorption amount was calculated in the same manner as above. The sample solution was prepared in the same manner as in Example 1. The results are shown in Table 6 below.

TEGO−51[F]は非イオン界面活性剤の配合がな
くともSCLにたいし吸着が少なく、さらに非イオン界
面活性剤を配合することによって、はとんど吸着はみら
れなくなった。また、塩類の配合も吸着抑制に影響はな
かった。
TEGO-51[F] showed little adsorption to SCL even without the addition of a nonionic surfactant, and by adding a nonionic surfactant, almost no adsorption was observed. Furthermore, the addition of salts had no effect on adsorption inhibition.

実施例5 低含水性5CL(7種)および高含水5CL(2種)を
、それぞれ下記の試料溶液5IIllに浸漬し、25℃
で24時間インキュベートしたのち、液中の防腐剤濃度
を定量し、実施例1と同様に吸着量を算出した。試料溶
液の調製法は実施例iと同様におこなった。結果を以下
の表7に示す。
Example 5 Low water content 5CL (7 types) and high water content 5CL (2 types) were immersed in the following sample solution 5IIll, and heated at 25°C.
After incubation for 24 hours, the preservative concentration in the solution was determined, and the adsorption amount was calculated in the same manner as in Example 1. The sample solution was prepared in the same manner as in Example i. The results are shown in Table 7 below.

表7゜ 防腐剤の吸W ffi (?7] /a度に対する%)
でき、また、点眼薬として具備すべき防腐力を有してい
る。
Table 7゜Preservative absorption Wffi (?7] /% of a degree)
It also has the preservative power that eye drops should have.

Claims (7)

【特許請求の範囲】[Claims] (1)グリシン型両性界面活性剤及び非イオン界面活性
剤を必須成分として含有するコンタクトレンズ用液剤。
(1) A contact lens solution containing a glycine-type amphoteric surfactant and a nonionic surfactant as essential components.
(2)無機塩類及び/又はエチレンジアミン四酢酸塩を
更に含有してなる請求項(1)に記載の液剤。
(2) The liquid preparation according to claim (1), further comprising an inorganic salt and/or ethylenediaminetetraacetate.
(3)コンタクトレンズ装着前および装着中の点眼薬で
ある請求項(1)に記載の液剤。
(3) The solution according to claim (1), which is an eye drop before and during contact lens wearing.
(4)コンタクトレンズ用殺菌保存剤である請求項(1
)に記載の液剤。
(4) Claim (1) which is a sterilizing preservative for contact lenses
).
(5)コンタクトレンズ用洗浄保存剤である請求項(1
)に記載の液剤。
(5) Claim (1) which is a cleaning preservative for contact lenses
).
(6)グリシン型両性界面活性剤が0.001〜0.1
w/v%配合される請求項(1)に記載の液剤。
(6) Glycine type amphoteric surfactant is 0.001 to 0.1
The liquid preparation according to claim (1), which is blended in w/v%.
(7)非イオン界面活性剤を0.001w/v%以上好
ましくは0.05w/v%以上0.5w/v%以下の濃
度範囲で含有する請求項(1)に記載の液剤。
(7) The liquid preparation according to claim (1), which contains the nonionic surfactant in a concentration range of 0.001 w/v% or more, preferably 0.05 w/v% or more and 0.5 w/v% or less.
JP1205372A 1989-08-08 1989-08-08 Liquid for contact lenses Expired - Fee Related JPH0816042B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1205372A JPH0816042B2 (en) 1989-08-08 1989-08-08 Liquid for contact lenses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1205372A JPH0816042B2 (en) 1989-08-08 1989-08-08 Liquid for contact lenses

Publications (2)

Publication Number Publication Date
JPH0368503A true JPH0368503A (en) 1991-03-25
JPH0816042B2 JPH0816042B2 (en) 1996-02-21

Family

ID=16505752

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1205372A Expired - Fee Related JPH0816042B2 (en) 1989-08-08 1989-08-08 Liquid for contact lenses

Country Status (1)

Country Link
JP (1) JPH0816042B2 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0590521A1 (en) * 1992-10-01 1994-04-06 Tomei Sangyo Kabushiki Kaisha Cleaning-preserving aqueous solution for contact lenses and method for cleaning and disinfecting a contact lens by means thereof
WO1997027879A1 (en) * 1996-02-02 1997-08-07 Asahi Kasei Kogyo Kabushiki Kaisha Solution for preserving and sterilizing contact lenses
JPH11180858A (en) * 1997-12-18 1999-07-06 Rohto Pharmaceut Co Ltd Eye drop containing refrigerant and used for contact lens
US5998488A (en) * 1994-12-26 1999-12-07 Lion Corporation Ophthalmic composition
EP1164183A1 (en) * 2000-06-14 2001-12-19 Menicon Co., Ltd. Solution for contact lenses
JP2003279906A (en) * 2003-03-17 2003-10-02 Rohto Pharmaceut Co Ltd Eye drop containing refrigerant and used for contact lens
JP2005036011A (en) * 2004-10-12 2005-02-10 Rohto Pharmaceut Co Ltd Eye drop for contact lens and containing refrigerant
JP2007269807A (en) * 2007-05-31 2007-10-18 Rohto Pharmaceut Co Ltd Eye drop for contact lens wearers, containing refrigerative agent
JPWO2005025539A1 (en) * 2003-09-10 2007-11-08 千寿製薬株式会社 Ophthalmic composition for contact lenses
JP2010163444A (en) * 2010-03-08 2010-07-29 Rohto Pharmaceut Co Ltd Eye drop for contact lens containing refrigerant
JP2013032393A (en) * 2012-11-09 2013-02-14 Rohto Pharmaceutical Co Ltd Eye drop for contact lens containing refrigerative agent
JP2013214113A (en) * 2005-07-07 2013-10-17 Rohto Pharmaceut Co Ltd Contact lens care method and composition
JP2015120705A (en) * 2015-01-07 2015-07-02 ロート製薬株式会社 Eye-drops for contact lenses containing refreshing agent
JP2016106156A (en) * 2016-03-22 2016-06-16 ロート製薬株式会社 Eye drop for contact lenses comprising refreshing agent
WO2021107035A1 (en) * 2019-11-29 2021-06-03 千寿製薬株式会社 Pharmaceutical composition for soft contact lens
CN114786726A (en) * 2019-11-29 2022-07-22 千寿制药株式会社 Pharmaceutical composition for soft contact lens

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62194217A (en) * 1986-02-19 1987-08-26 チバ−ガイギ− アクチエンゲゼルシヤフト Ampholytic surfactant solution for cleaning soft contact lens or antiseptic preservation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62194217A (en) * 1986-02-19 1987-08-26 チバ−ガイギ− アクチエンゲゼルシヤフト Ampholytic surfactant solution for cleaning soft contact lens or antiseptic preservation

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0590521A1 (en) * 1992-10-01 1994-04-06 Tomei Sangyo Kabushiki Kaisha Cleaning-preserving aqueous solution for contact lenses and method for cleaning and disinfecting a contact lens by means thereof
US5401431A (en) * 1992-10-01 1995-03-28 Tomei Sangyo Kabushiki Kaisha Cleaning-preserving aqueous solution for contact lenses and method for cleaning and disinfecting a contact lens by means thereof
US5998488A (en) * 1994-12-26 1999-12-07 Lion Corporation Ophthalmic composition
WO1997027879A1 (en) * 1996-02-02 1997-08-07 Asahi Kasei Kogyo Kabushiki Kaisha Solution for preserving and sterilizing contact lenses
JPH11180858A (en) * 1997-12-18 1999-07-06 Rohto Pharmaceut Co Ltd Eye drop containing refrigerant and used for contact lens
EP1164183A1 (en) * 2000-06-14 2001-12-19 Menicon Co., Ltd. Solution for contact lenses
US6417144B2 (en) 2000-06-14 2002-07-09 Menicon., Ltd. Solution for contact lenses
JP2003279906A (en) * 2003-03-17 2003-10-02 Rohto Pharmaceut Co Ltd Eye drop containing refrigerant and used for contact lens
JPWO2005025539A1 (en) * 2003-09-10 2007-11-08 千寿製薬株式会社 Ophthalmic composition for contact lenses
JP5123484B2 (en) * 2003-09-10 2013-01-23 千寿製薬株式会社 Ophthalmic composition for contact lenses
JP2005036011A (en) * 2004-10-12 2005-02-10 Rohto Pharmaceut Co Ltd Eye drop for contact lens and containing refrigerant
JP2013214113A (en) * 2005-07-07 2013-10-17 Rohto Pharmaceut Co Ltd Contact lens care method and composition
JP2007269807A (en) * 2007-05-31 2007-10-18 Rohto Pharmaceut Co Ltd Eye drop for contact lens wearers, containing refrigerative agent
JP2010163444A (en) * 2010-03-08 2010-07-29 Rohto Pharmaceut Co Ltd Eye drop for contact lens containing refrigerant
JP2013032393A (en) * 2012-11-09 2013-02-14 Rohto Pharmaceutical Co Ltd Eye drop for contact lens containing refrigerative agent
JP2015120705A (en) * 2015-01-07 2015-07-02 ロート製薬株式会社 Eye-drops for contact lenses containing refreshing agent
JP2016106156A (en) * 2016-03-22 2016-06-16 ロート製薬株式会社 Eye drop for contact lenses comprising refreshing agent
WO2021107035A1 (en) * 2019-11-29 2021-06-03 千寿製薬株式会社 Pharmaceutical composition for soft contact lens
JPWO2021107035A1 (en) * 2019-11-29 2021-06-03
CN114786650A (en) * 2019-11-29 2022-07-22 千寿制药株式会社 Pharmaceutical composition for soft contact lens
CN114786726A (en) * 2019-11-29 2022-07-22 千寿制药株式会社 Pharmaceutical composition for soft contact lens

Also Published As

Publication number Publication date
JPH0816042B2 (en) 1996-02-21

Similar Documents

Publication Publication Date Title
AU621689B2 (en) Aqueous ophthalmic solutions and method for preserving same
US3882036A (en) Contact lens cleaning and storing composition including nonionic surfactant, benzalkonium chloride and Na{hd 3{b EDTA
US4046706A (en) Contact lens cleaning composition
RU2448736C1 (en) Ophthalmologic composition with amphoteric surface-active substance hyaluronic acid
US3639576A (en) Resterilizing contact lens solution
JPS608484B2 (en) Cleaning preservative for contact lenses
JPS58171499A (en) Disinfectant solution for hydrophilic contact lens
JPH0368503A (en) Liquid medicine for contact lens
JP2008510568A (en) Composition comprising trialkanolamine alkoxylate buffer
JP5938616B2 (en) Contact lens solution
US20030118472A1 (en) Disinfecting and cleaning system for contact lenses
US20100178317A1 (en) Lens Care Solutions with Hyaluronic Acid
JP2006511837A (en) Use of multifunctional surfactants to clean contact lenses
CN1182877C (en) Composition for treaitng contact lens and its application
WO2006026170A1 (en) Compositions containing n,n,n&#39;,n&#39;-tetrakis(hydroxyalkyl)diamine- or n,n,n&#39;,n&#39;-tetrakis(hydroxyalkoxy) diamine-based buffers
JP2005513546A (en) Composition for treating contact lenses
JPH08503701A (en) Ophthalmic solutions and methods of use
WO2001057172A1 (en) Composition of multi-purpose solution for treating contact lens
HU209538B (en) Set and cleaning composition for treating contactlenses
JPH09206362A (en) Sterilizing and cleaning composition for contact lens and sterilizing and cleaning method for contact lens using the same
JP2008501026A (en) Gentle preservation composition
JP2004077902A (en) Liquid formulation for contact lens
JP4532720B2 (en) Methods for cleaning, disinfecting and storing soft contact lens solutions and soft contact lenses
JP5989326B2 (en) Solvent for contact lenses
JPS6169023A (en) Solution containing antiseptic for wetting soft contact lensand sedation inside eye and method therefor

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080221

Year of fee payment: 12

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090221

Year of fee payment: 13

LAPS Cancellation because of no payment of annual fees